Filing metadata

Accession number
0001209191-21-064769
Form type
Form 3
Filer
Spyre Therapeutics, Inc.
CIK
CIK 1636282
Filed
Nov 16, 2021
Reporting period
Nov 12, 2021
Description
Initial ownership

Explore SEC Filings Hub